Best SellerAODT-0001
Semaglutide
GLP-1 receptor agonist for type 2 diabetes and chronic weight management. Widely used in clinical and wellness protocols.
Priority Sales Hotline
Tap to chat with us
We use cookies
We use essential cookies to make our site work, and optional analytics & preference cookies to improve your experience. See our Cookie Policy.

Product Catalog
GMP-grade, research-grade, and cosmetic-grade peptides across 9 therapeutic categories. All products come with full CoA, HPLC, and MS documentation.
Our peptide catalog spans weight loss and metabolic peptides including semaglutide and tirzepatide, growth hormone secretagogues such as CJC-1295 and ipamorelin, regenerative peptides like BPC-157 and TB-500, cosmetic and anti-aging bioactives, neuropeptides, immune modulators, and custom combination formulas.
Showing 9 of 51 products
Best SellerAODT-0001
GLP-1 receptor agonist for type 2 diabetes and chronic weight management. Widely used in clinical and wellness protocols.
HotAODT-0002
Dual GIP/GLP-1 receptor agonist. Superior weight loss efficacy with improved glycemic control in clinical trials.
NewAODT-0003
Long-acting amylin analogue for appetite suppression and weight reduction. Often combined with semaglutide.
NewAODT-0004
Triple agonist targeting GLP-1, GIP, and glucagon receptors. Promising next-generation obesity treatment.

AODT-0005
Modified fragment of human growth hormone. Stimulates fat metabolism without affecting blood sugar or growth.

AODT-0006
Native GLP-1 receptor agonist. Regulates glucose-dependent insulin secretion and gastric emptying.
NewAODT-0007
GLP-1/glucagon dual receptor agonist developed for obesity and NASH. Strong clinical pipeline in Asia.

AODT-0008
GLP-1/glucagon receptor dual agonist. Investigated for obesity and metabolic-associated steatohepatitis (MASH).

AODT-0009
GLP-1 receptor agonist with C16 fatty acid conjugation for extended half-life. Proven weight management therapy.
Any sequence, any scale. OEM & private label available.
Request a custom sequence